Cargando…

Significant Differences in the Development of Acquired Resistance to the MDM2 Inhibitor SAR405838 between In Vitro and In Vivo Drug Treatment

SAR405838 is a potent and specific MDM2 inhibitor currently being evaluated in Phase I clinical trials for the treatment of human cancer. Using the SJSA-1 osteosarcoma cell line which harbors an amplified MDM2 gene and wild-type p53, we have investigated the acquired resistance mechanisms both in vi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoffman-Luca, C. Gianna, Yang, Chao-Yie, Lu, Jianfeng, Ziazadeh, Daniel, McEachern, Donna, Debussche, Laurent, Wang, Shaomeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466389/ https://www.ncbi.nlm.nih.gov/pubmed/26070072 http://dx.doi.org/10.1371/journal.pone.0128807

Ejemplares similares

Design of Chemically Stable, Potent, and Efficacious MDM2 Inhibitors That Exploit the Retro-Mannich Ring-Opening-Cyclization Reaction Mechanism in Spiro-oxindoles
por: Aguilar, Angelo, et al.
Publicado: (2014)

Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastoma
por: Lu, Jiaxiong, et al.
Publicado: (2016)

A highly potent PROTAC androgen receptor (AR) degrader ARD-61 effectively inhibits AR-positive breast cancer cell growth in vitro and tumor growth in vivo
por: Zhao, Lijie, et al.
Publicado: (2020)

BM-1197: A Novel and Specific Bcl-2/Bcl-xL Inhibitor Inducing Complete and Long-Lasting Tumor Regression In Vivo
por: Bai, Longchuan, et al.
Publicado: (2014)

Selective inhibition of cullin 3 neddylation through covalent targeting DCN1 protects mice from acetaminophen-induced liver toxicity
por: Zhou, Haibin, et al.
Publicado: (2021)

TP53 mutations emerge with HDM2 inhibitor SAR405838 treatment in de-differentiated liposarcoma
por: Jung, Joonil, et al.
Publicado: (2016)

Discovery of 4-((3′R,4′S,5′R)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-ethyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Development
por: Aguilar, Angelo, et al.
Publicado: (2017)

Small-Molecule Inhibitors of the MDM2–p53 Protein–Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment: Miniperspective
por: Zhao, Yujun, et al.
Publicado: (2014)

A phase I study of the HDM2 antagonist SAR405838 combined with the MEK inhibitor pimasertib in patients with advanced solid tumours
por: de Weger, Vincent A., et al.
Publicado: (2018)

Potent and Selective Small-Molecule Inhibitors of cIAP1/2 Proteins Reveal That the Binding of Smac Mimetics to XIAP BIR3 Is Not Required for Their Effective Induction of Cell Death in Tumor Cells
por: Sun, Haiying, et al.
Publicado: (2014)

Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression
por: Zhou, Bing, et al.
Publicado: (2017)

Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancers
por: Hata, Aaron N, et al.
Publicado: (2017)

Economics : a contemporary introduction /
por: McEachern, William A.
Publicado: (1994)

Economía : una introducción contemporánea
por: McEachern, William A.
Publicado: (1998)

Microeconomía : una introducción contemporánea /
por: McEachern, William A.
Publicado: (2003)

Macroeconomía : una introducción contemporánea
por: McEachern, William A.
Publicado: (1998)

Microeconomía : una introducción contemporánea /
por: McEachern, William A.
Publicado: (1998)

Economía : una introducción contemporánea
por: McEachern, William A.
Publicado: (2003)

Macroeconomía : una introducción contemporánea
por: McEachern, William A.
Publicado: (2003)

Transgenic Epigenetics: Using Transgenic Organisms to Examine Epigenetic Phenomena
por: McEachern, Lori A.
Publicado: (2012)

EXPERIMENTAL HYPERTHYROIDISM AND ITS EFFECT UPON THE MYOCARDIUM IN GUINEA PIGS AND RABBITS
por: Rake, Geoffrey, et al.
Publicado: (1931)

MI-219-Zinc Combination: a new Paradigm in MDM2 Inhibitor Based Therapy
por: Azmi, Asfar S., et al.
Publicado: (2010)

Long Telomeres Produced by Telomerase-Resistant Recombination Are Established from a Single Source and Are Subject to Extreme Sequence Scrambling
por: Xu, Jianing, et al.
Publicado: (2012)

E2F1-Dependent Oncogenic Addiction of Melanoma Cells to MDM2
por: Verhaegen, Monique, et al.
Publicado: (2011)

Public Health Surveillance Studies of Alcohol Industry Market and Political Strategies: A Systematic Review
por: McCambridge, Jim, et al.
Publicado: (2019)

The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth In Vivo and Potentiates Radiotherapy
por: Ingelshed, Katrine, et al.
Publicado: (2022)

Efficiency of communication between tumour cells in collagen gel cultures
por: Miller, F.R., et al.
Publicado: (1990)

Sequential alteration of peanut agglutinin binding-glycoprotein expression during progression of murine mammary neoplasia.
por: Rak, J. W., et al.
Publicado: (1992)

A potent small-molecule inhibitor of the DCN1-UBC12 interaction that selectively blocks cullin 3 neddylation
por: Zhou, Haibin, et al.
Publicado: (2017)

The FHA and BRCT domains recognize ADP-ribosylation during DNA damage response
por: Li, Mo, et al.
Publicado: (2013)

Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
por: Zhu, Haohao, et al.
Publicado: (2022)

Home-Based Multidisciplinary Rehabilitation following Hip Fracture Surgery: What Is the Evidence?
por: Donohue, Kathleen, et al.
Publicado: (2013)

Vasospasm following low-velocity penetrating pediatric intracranial trauma
por: Almojuela, Alysa, et al.
Publicado: (2022)

The Dual Interactions of p53 with MDM2 and p300: Implications for the Design of MDM2 Inhibitors
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2019)

Epstein Barr virus–positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo
por: Zhang, Xiaoshan, et al.
Publicado: (2022)

Fortifying p53 – beyond Mdm2 inhibitors
por: Sriraman, Anusha, et al.
Publicado: (2016)

Expression and Clinical Significance of MDM2 in Non-Functioning PitNETs
por: Yao, Xiaohui, et al.
Publicado: (2023)

Anatomy of Mdm2 and Mdm4 in evolution
por: Tan, Ban Xiong, et al.
Publicado: (2017)

Promoting Community Conversations About Research to End Suicide: learning and behavioural outcomes of a training-of-trainers model to facilitate grassroots community health education to address Indigenous youth suicide prevention
por: Wexler, Lisa, et al.
Publicado: (2017)

Intake of Fruits, Vegetables, and Sugar-Sweetened Beverages among a Sample of Children in Rural Northern Ontario, Canada
por: Button, Brenton L. G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pdt3hbuj5ik700on2n8k25m9lm